Deucravacitinib Long-Term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results from the Phase 3 POETYK PSO Program. J of Skin 2023, 7 (2), s118. https://doi.org/10.25251/skin.7.supp.118.